Ginkgo Biloba
Last reviewed October 2026 · Based on 11 studies
Bottom line
Ginkgo is among the most studied natural nootropics, with the clearest signals on perceptual and motor tasks. But trials of memory and thinking are mixed and often flawed, and two large randomised trials found a standard extract did not prevent dementia or Alzheimer's disease. Side effects in trials matched placebo, but ginkgo can interact with blood thinners such as warfarin.
What it helps with
- Improves memory and thinking in healthy adults — Mixed results, evidence grade C (Limited). Reviews find results consistently unclear and most trials at high risk of bias; the newest network meta-analysis ranked ginkgo below bacopa for memory.
- Prevents dementia and Alzheimer's disease — No effect, evidence grade B (Moderate). Two large, well-conducted randomised trials found no reduction in dementia or Alzheimer's diagnoses over five to six years.
- Slows age-related cognitive decline — No effect, evidence grade B (Moderate). One large randomised trial measured rates of decline directly over six years and found no difference in any domain.
- Improves perceptual and motor function — Benefit, evidence grade C (Limited). Systematic review of human studies rated ginkgo most relevant for these domains, but the finding is a qualitative summary of heterogeneous studies.
What it is
Ginkgo biloba is an extract from the leaves of the ginkgo tree, standardised in products such as EGb 761 and sold as a supplement for memory and circulation [1]. Trials in older adults have used 120 mg twice a day (240 mg a day) for up to six years [1] [2], while a 2026 comparison in healthy adults grouped doses from 60 mg a day up to 240 mg a day and above [3].
What the research says
A 2023 systematic review of plant nootropics concluded ginkgo was the most relevant option for perceptual and motor functions [4]. For memory, a 2026 network meta-analysis of 29 trials (2,107 healthy adults) ranked both ginkgo doses below high-dose bacopa on working memory [3], and a review of herbal supplements in older adults found ginkgo's effects on thinking "consistently unclear", with most ginkgo trials at high risk of bias [5]. A small 2008 pilot trial (118 people, 42 months) found no reduced risk of progression to cognitive impairment in its main analysis [6]. For prevention, the Ginkgo Evaluation of Memory study gave 3,069 adults aged 75 and older 240 mg a day for a median of 6.1 years: dementia rates were similar to placebo (hazard ratio 1.12, 95% CI 0.94-1.33), and an analysis of the same trial found no difference in the rate of decline on memory, attention, language or executive-function tests [1] [2]. The French GuidAge trial (2,854 adults with memory complaints, five years) likewise found no reduction in Alzheimer's diagnoses (hazard ratio 0.84, 95% CI 0.60-1.18) [7].
Doses used in studies
Prevention trials used 120 mg twice a day (240 mg a day) of standardised extract for five to six years [1] [7]. The 2026 review grouped ginkgo doses as 60 to under 240 mg a day and 240 mg a day or more [3].
Safety and interactions
- Common side effects: in trials of older adults, ginkgo's side effects matched placebo; reported complaints included stomach upset, dizziness, headaches and sleep disturbance [5].
- Upper limits: no established upper intake limit; trials have used 240 mg a day for over six years, with side effects similar to placebo [1].
- Bleeding and interactions: a meta-analysis of 18 trials (1,985 adults) found no clear effect on clotting tests and no increased bleeding risk from standard extracts [8], but a systematic review lists ginkgo among supplements reported to interact with warfarin, with bleeding events in some reports [9], and a small pilot trial observed more strokes and mini-strokes in the ginkgo group [6].
- Pregnancy and breastfeeding: ginkgo is advised against in pregnancy — it may prolong bleeding time around labour — and its safety during breastfeeding is unknown [10].
- Conditions: people taking blood thinners or with a bleeding disorder should check with a doctor first [9].
Caveats and open questions
Ginkgo has been tested for decades without producing a consistent cognitive benefit in healthy people [5], and the prevention trials found no dementia benefit [1] [7]. The signal for perceptual and motor tasks comes from heterogeneous studies rather than a pooled trial result [4].
References
- Ginkgo biloba for prevention of dementia: a randomized controlled trial.. JAMA, 2008.
- Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.. JAMA, 2009.
- Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.. Phytomedicine, 2026.
- Plant-derived nootropics and human cognition: A systematic review.. Crit Rev Food Sci Nutr, 2023.
- A systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with and without subjective cognitive impairment.. Syst Rev, 2023.
- A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.. Neurology, 2008.
- Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial.. Lancet Neurol, 2012.
- Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis.. Pharmacotherapy, 2011.
- Warfarin and food, herbal or dietary supplement interactions: A systematic review.. Br J Clin Pharmacol, 2021.
- Safety and efficacy of ginkgo (Ginkgo biloba) during pregnancy and lactation.. Can J Clin Pharmacol, 2006.